What is the ticker symbol for ADMA Biologics?

ADMA Biologics trades under the ticker ADMA on NASDAQ.

What sector does ADMA Biologics operate in?

ADMA Biologics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ADMA in a portfolio?

PortView shows ADMA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ADMA Biologics (ADMA) Stock Analysis

NASDAQHealthcareBiotechnology

$9.54+2.20%

1-year price historyRange $7.60 – $20.38

52-week range$9.54

$7.21$20.46

What ADMA Biologics does

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) treatments prescribed for primary humoral immunodeficiency (PI). Additionally, the company offers Nabi-HB, utilized for immediate treatment following acute exposure to the Hepatitis B virus and other specified exposures. Beyond its existing offerings, ADMA is actively developing a pipeline of new plasma-derived therapeutics. This includes immunoglobulin products specifically targeting the prevention and treatment of S. pneumonia infections. The company also oversees its own facilities for source plasma collection. Product distribution is managed through a comprehensive network involving independent distributors, sales agents, specialty pharmacies, and other alternative healthcare providers. ADMA Biologics, Inc. was founded in 2004 and maintains its corporate headquarters in Ramsey, New Jersey.

Key metrics

Market cap

$2.21B

P/E (TTM)

13.43

EPS (TTM)

$0.71

Beta

0.77

Dividend yield

0.00%

Revenue / share

$2.24

50-day avg

$9.09

200-day avg

$12.73

52-week high

$20.46

52-week low

$7.21

CEO

Adam S. Grossman

ETFs linked to ADMA

Broad-market and Healthcare sector ETFs an investor holding ADMA Biologics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ADMA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ADMA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ADMA Biologics?: ADMA Biologics trades under the ticker ADMA on NASDAQ.
Which exchange is ADMA listed on?: ADMA is listed on NASDAQ.
What sector does ADMA Biologics operate in?: ADMA Biologics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ADMA in a portfolio?: PortView shows ADMA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.